Approval of oral tablets for Escafe and Beximco

Two Bangladeshi pharmaceutical companies told the media on Thursday that their two tablets had been approved.

Approval of oral tablets for Escafe and Beximco

Director of the Department of Drug Administration. Ayub Hossain told bdnews24.com, “They applied to us. Today (Paxlovid) use has been given urgent approval. ”

Pfizer, a U.S. company, has developed Paxlovid tablets in combination with conventional Ritonavir with the newly invented Nirametrelvi drug.

Escafe will market the drug under the name Paxovir. And Beximco is bringing this drug to the market under the name Bexovid.

Health Minister Zahid Malek said at a function in Manikganj on Thursday that several more pharmaceutical companies in the country would be given approval.

“Pfizer’s drug has been approved by the American FDI. This will reduce the need for hospitalization by 8 percent. Mortality rates will also decrease. Two or three more companies will be approved soon. They will also produce and market the drug. ”

Speaking on the occasion, the health minister said that the medicine should be taken for five days. It will cost 18 thousand rupees to complete the whole course.

Mujahidul Islam, director (marketing and sales) of Escafe Pharmaceuticals, told a news conference on Thursday that patients with mild to moderate symptoms of coronavirus would be able to take the drug. It should be eaten within five days of the onset of symptoms. “

In a press release, Beximco Pharma said, “We are delighted to bring this (Paxlovid) groundbreaking drug. We reaffirm our commitment to make medical care readily available as soon as possible.

“We believe that Bexovid will play a strong role in combating the Corona epidemic, as it has efficacy against the fast-moving Omicron.”

On December 22, the US Food and Drug Administration (FDA) approved the emergency use of nirmatrelvi and ritonavir tablets for the treatment of coronavirus. Adults as well as children up to 12 years of age can take this medicine.

For the treatment of Covid-19, two Nirmatrelvi and one Ritonavir should be taken twice a day for a total of 5 days. Only take this medicine as advised by the doctor. More about Approval of oral tablets for Escafe and Beximco will be published here.